Surviving Against All Odds: Analysis of 6 Case Studies of Patients With Cancer Who Followed the Gerson Therapy A. Molassiotis, RN, PhD, and P. Peat, RGN, DiplPallCare Case 4 Case 4 is a 33-year-old woman (born in 1973) diagnosed with anaplastic non-Hodgkin lymphoma following core needle biopsy of an axillary mass diagnosed in August 1999 at the age of 25. The biopsy of the mass showed heavy infiltration by an anaplastic large cell lymphoma of null type, with cells being ALK-1 positive, graded at stage IIIa. Concurrent bone marrow biopsy appeared normal and uninvolved by tumor. International performance index was graded at 2. A CT scan was initially reported as showing para-aortic disease in the abdomen but no evidence of splenic involvement. The findings of the CT were considered equivocal, but a scintimammograph did show increased uptake in the para-aortic region. The treatment plan was to proceed with CHOP chemotherapy, and she had only 1 cycle of chemotherapy in early October 1999 before deciding to discontinue treatment of her own accord. At the end of October, she commenced the Gerson regimen. She was taking no concurrent medication or other treatments at the time or since. A CT scan of the chest and abdomen on August 9, 2001, blood tests, clinical examination by a hematologist, and all subsequent examinations to date have shown her to be free of disease. She is currently alive and well based on physician notes (2006). Integr Cancer Ther 2007; 6; 80 Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.